Depomed Stock Upgraded After Pain Drug Deal, Layoffs

DEPO stock could clear its 120-day moving average for the first time since January

Dec 5, 2017 at 9:24 AM
facebook X logo linkedin


Shares of Depomed Inc (NASDAQ:DEPO) are almost 12% higher in electronic trading, after the biotech said it is licensing the sales rights to its opioid pain drugs, Nucynta IR and Nucynta ER, to Collegium Pharmaceutical (COLL). As such, DEPO is also slashing its workforce by 40%, and plans to move its headquarters out of California -- with the company scouting potential sites in the Midwest or along the East Coast.

Adding to the bullish bias is an upgrade to "buy" from "neutral" and price-target hike to $9 from $6 at Mizuho, which called Depomed's exit from the opioid business a "strong positive." This positive analyst attention runs counter to the withstanding setup, with six of seven brokerages maintaining a lukewarm "hold" rating at last night's close.

And the skepticism toward DEPO stock is seen elsewhere on Wall Street, too. Short interest currently accounts for 20.63% of the stock's available float, or 10.45 times the average daily pace of trading.

Looking at the charts, DEPO has struggled for most of the year, shedding 62.2% over the past 12 months, based on last night's close at $7.15. However, since hitting a six-year low of $4.31 on Nov. 2, Depomed stock is up almost 66%. Plus, today's projected breakout could have the stock closing north of its 120-day moving average for the first time since Jan. 4, and filling some of its early August bear gap.

 

Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on C3.ai calls
238.5% GAIN on Oracle calls

 
 
 


 
 

Rainmaker Ads CGI